{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:29:56Z","timestamp":1768732196084,"version":"3.49.0"},"reference-count":49,"publisher":"Radiation Research Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2019,9,26]]},"DOI":"10.1667\/rr15440.1","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T18:54:39Z","timestamp":1569524079000},"page":"602","source":"Crossref","is-referenced-by-count":11,"title":["Mitigating Effects of 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) on Hematopoietic Acute Radiation Syndrome after Total-Body Ionizing Irradiation in Mice"],"prefix":"10.1667","volume":"192","author":[{"given":"Yong-Jae","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinseon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Systems Biology and Bioengineering, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyun","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Systems Biology and Bioengineering, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Young","family":"Sohn","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Wha","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Systems Biology and Bioengineering, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1243","reference":[{"key":"6","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, AN Berg, et al.  \"Expert Opin Drug Discov.\"  10, \"Animal models for acute radiation syndrome drug discovery.\" 497 (2015)","DOI":"10.1517\/17460441.2015.1023290"},{"key":"47","doi-asserted-by":"crossref","unstructured":"AK Shadad, FJ Sullivan, JD Martin, et al.  \"World J Gastroenterol.\"  19, \"Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.\" 185 (2013)","DOI":"10.3748\/wjg.v19.i2.185"},{"key":"24","doi-asserted-by":"crossref","unstructured":"GM Kendall, CR Muirhead, BH MacGibbon, et al.  \"BMJ.\"  304, \"Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers.\" 220 (1992)","DOI":"10.1136\/bmj.304.6821.220"},{"key":"39","doi-asserted-by":"crossref","unstructured":"ME Lomax, LK Folkes, P O'Neill,  \"Clin Oncol (R Coll Radiol).\"  25, \"Biological consequences of radiation-induced DNA damage: relevance to radiotherapy.\" 578 (2013)","DOI":"10.1016\/j.clon.2013.06.007"},{"key":"46","doi-asserted-by":"crossref","unstructured":"AK Shadad, FJ Sullivan, JD Martin, et al.  \"World J Gastroenterol.\"  19, \"Gastrointestinal radiation injury: Prevention and treatment.\" 199 (2013)","DOI":"10.3748\/wjg.v19.i2.199"},{"key":"1","doi-asserted-by":"crossref","unstructured":"L Heslet, C Bay, S Nepper-Christensen,  \"Int J Gen Med.\"  5, \"Acute radiation syndrome (ARS) - treatment of the reduced host defense.\" 105 (2012)","DOI":"10.2147\/IJGM.S22177"},{"key":"2","doi-asserted-by":"crossref","unstructured":"GH Anno, SJ Baum, HR Withers, et al.  \"Health Phys.\"  56, \"Symptomatology of acute radiation effects in humans after exposure to doses of 0.5\u201330 Gy.\" 821 (1989)","DOI":"10.1097\/00004032-198906000-00001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"DM Christensen, CJ Iddins, SJ Parrillo, et al.  \"J Am Osteopath Assoc.\"  114, \"Management of ionizing radiation injuries and illnesses, part 4: acute radiation syndrome.\" 702 (2014)","DOI":"10.7556\/jaoa.2014.138"},{"key":"5","doi-asserted-by":"crossref","unstructured":"VK Singh  and TM Seed  \"Int J Radiat Biol.\"  93, \"A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.\" 851 (2017)","DOI":"10.1080\/09553002.2017.1332438"},{"key":"7","doi-asserted-by":"crossref","unstructured":"VK Singh, PL Romaine, VL Newman,  \"Expert Opin Biol Ther.\"  15, \"Biologics as countermeasures for acute radiation syndrome: where are we now?\" 465 (2015)","DOI":"10.1517\/14712598.2015.986453"},{"key":"11","doi-asserted-by":"crossref","unstructured":"AM Farese, AW Bennett, AM Gibbs, et al.  \"Health Phys.\"  116, \"Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS mortality and hematopoietic recovery in nonhuman primates after 10 Gy irradiation with 2.5% bone-marrow sparing.\" 339 (2019)","DOI":"10.1097\/HP.0000000000000878"},{"key":"12","doi-asserted-by":"crossref","unstructured":"VK Singh  and TM Seed  \"Drugs Today (Barc).\"  54, \"An update on sargramostim for treatment of acute radiation syndrome.\" 679 (2018)","DOI":"10.1358\/dot.2018.54.11.2899370"},{"key":"13","doi-asserted-by":"crossref","unstructured":"TG Adams, LE Sumner, R Casagrande,  \"Health Phys.\"  113, \"Estimating risk of hematopoietic acute radiation syndrome in children.\" 452 (2017)","DOI":"10.1097\/HP.0000000000000720"},{"key":"14","doi-asserted-by":"crossref","unstructured":"S. Hu,  \"Health Phys.\"  111, \"Linking doses with clinical scores of hematopoietic acute radiation syndrome.\" 337 (2016)","DOI":"10.1097\/HP.0000000000000529"},{"key":"15","doi-asserted-by":"crossref","unstructured":"VK Singh  and M Hauer-Jensen  \"Int J Mol Sci.\"  17, \"Gamma-Tocotrienol as a promising countermeasure for acute radiation syndrome: current status.\"  (2016)","DOI":"10.3390\/ijms17050663"},{"key":"16","doi-asserted-by":"crossref","unstructured":"M Boada Burutaran, R Guadagna, S Grille, et al.  \"Rev Bras Hematol Hemoter.\"  37, \"Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay.\" 28 (2015)","DOI":"10.1016\/j.bjhh.2014.11.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"M Swinkels, M Rijkers, J Voorberg, et al.  \"Front Immunol.\"  9, \"Emerging concepts in immune thrombocytopenia.\" 880 (2018)","DOI":"10.3389\/fimmu.2018.00880"},{"key":"18","doi-asserted-by":"crossref","unstructured":"JP Williams, SL Brown, GE Georges, et al.  \"Radiat Res.\"  173, \"Animal models for medical countermeasures to radiation exposure.\" 557 (2010)","DOI":"10.1667\/RR1880.1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"HO Yang, JS Park, SH Cho, et al.  \"Biol Pharm Bull.\"  27, \"Stimulatory effects of monoacetyldiglycerides on hematopoiesis.\" 1121 (2004)","DOI":"10.1248\/bpb.27.1121"},{"key":"20","doi-asserted-by":"crossref","unstructured":"J Jeong, YJ Kim, SY Yoon, et al.  \"PLoS One.\"  11, \"PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) modulates eosinophil chemotaxis by regulating CCL26 expression from epithelial cells.\" e0151758 (2016)","DOI":"10.1371\/journal.pone.0151758"},{"key":"21","doi-asserted-by":"crossref","unstructured":"J Jeong, Y-J Kim, DY Lee, et al.  \"Cell Biosci.\"  9, \"1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) attenuates gemcitabine-induced neutrophil extravasation.\" 4 (2019)","DOI":"10.1186\/s13578-018-0266-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"D Oh, MH Kim, TJ Song, et al.  \"World J Oncol.\"  6, \"1-Pamitoyl-2-linoleoyl-3-acetyl-rac-glycerol may reduce incidence of gemcitabine-induced neutropenia: a pilot case-controlled study.\" 410 (2015)","DOI":"10.14740\/wjon937e"},{"key":"23","doi-asserted-by":"crossref","unstructured":"N Yoo, HR Lee, SH Shin, et al.  \"Cancer Lett.\"  377, \"PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the therapeutic effect of pegfilgrastim on gemcitabine-induced neutropenia.\" 25 (2016)","DOI":"10.1016\/j.canlet.2016.04.025"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Z Gluzman-Poltorak, V Vainstein, LA Basile,  \"Radiat Res.\"  184, \"Association of hematological nadirs and survival in a nonhuman primate model of hematopoietic syndrome of acute radiation syndrome.\" 226 (2015)","DOI":"10.1667\/RR13962.1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"SJ. Slichter,  \"Transfus Med Rev.\"  18, \"Relationship between platelet count and bleeding risk in thrombocytopenic patients.\" 153 (2004)","DOI":"10.1016\/j.tmrv.2004.03.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"R. Stasi,  \"Hematology Am Soc Hematol Educ Program.\"  2012, \"How to approach thrombocytopenia.\" 191 (2012)","DOI":"10.1182\/asheducation.V2012.1.191.3798260"},{"key":"28","doi-asserted-by":"crossref","unstructured":"L Chow, R Aslam, ER Speck, et al.  \"Blood.\"  115, \"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.\" 1247 (2010)","DOI":"10.1182\/blood-2009-09-244772"},{"key":"29","doi-asserted-by":"crossref","unstructured":"JE Groopman  and LM Itri  \"J Natl Cancer Inst.\"  91, \"Chemotherapy-induced anemia in adults: incidence and treatment.\" 1616 (1999)","DOI":"10.1093\/jnci\/91.19.1616"},{"key":"30","doi-asserted-by":"crossref","unstructured":"GJ Izaks, RG Westendorp, DL Knook,  \"JAMA.\"  281, \"The definition of anemia in older persons.\" 1714 (1999)","DOI":"10.1001\/jama.281.18.1714"},{"key":"31","doi-asserted-by":"crossref","unstructured":"VK Singh, PL Romaine, TM Seed,  \"Health Phys.\"  108, \"Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the Strategic National Stockpile.\" 607 (2015)","DOI":"10.1097\/HP.0000000000000279"},{"key":"32","doi-asserted-by":"crossref","unstructured":"L Cerezo  and I Macia  \"Rep Pract Oncol Radiother.\"  17, \"Acute radiation syndrome and Fukushima: a watershed moment?\" 1 (2012)","DOI":"10.1016\/j.rpor.2012.01.001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"G Waterman, K Kase, I Orion, et al.  \"Health Phys.\"  113, \"Selective shielding of bone marrow: an approach to protecting humans from external gamma radiation.\" 195 (2017)","DOI":"10.1097\/HP.0000000000000688"},{"key":"34","doi-asserted-by":"crossref","unstructured":"YJ Kim, JM Shin, SH Shin, et al.  \"Oncotarget.\"  8, \"1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ameliorates arthritic joints through reducing neutrophil infiltration mediated by IL-6\/ STAT3 and MIP-2 activation.\" 96636 (2017)","DOI":"10.18632\/oncotarget.19384"},{"key":"35","doi-asserted-by":"crossref","unstructured":"YE Ko, SY Yoon, SY Ly, et al.  \"J Cell Biochem.\"  119, \"1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reduces hepatic injury in concanavalin A-treated mice.\" 1392 (2018)","DOI":"10.1002\/jcb.26299"},{"key":"36","doi-asserted-by":"crossref","unstructured":"SY Yoon, HB Kang, YE Ko, et al.  \"Immune Netw.\"  15, \"1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) modulates Th2 immunity through attenuation of IL-4 expression.\" 100 (2015)","DOI":"10.4110\/in.2015.15.2.100"},{"key":"37","doi-asserted-by":"crossref","unstructured":"HR Lee, N Yoo, JH Kim, et al.  \"Front Oncol.\"  6, \"The therapeutic effect of PLAG against oral mucositis in hamster and mouse model.\" 209 (2016)","DOI":"10.3389\/fonc.2016.00209"},{"key":"38","doi-asserted-by":"crossref","unstructured":"JF. Ward,  \"Prog Nucleic Acid Res Mol Biol.\"  35, \"DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability.\" 95 (1988)","DOI":"10.1016\/S0079-6603(08)60611-X"},{"key":"41","doi-asserted-by":"crossref","unstructured":"E Yoritsune, M Furuse, H Kuwabara, et al.  \"J Radiat Res.\"  55, \"Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis.\" 803 (2014)","DOI":"10.1093\/jrr\/rru017"},{"key":"42","doi-asserted-by":"crossref","unstructured":"H Lai  and NP Singh  \"Int J Radiat Biol.\"  69, \"Single- and double-strand DNA breaks in rat brain cells after acute exposure to radiofrequency electromagnetic radiation.\" 513 (1996)","DOI":"10.1080\/095530096145814"},{"key":"43","unstructured":"R Okayasu, K Suetomi, Y Yu, et al.  \"Cancer Res.\"  60, \"A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB\/c mouse.\" 4342 (2000)"},{"key":"45","doi-asserted-by":"crossref","unstructured":"MT Teo, D Sebag-Montefiore, CF Donnellan,  \"Clin Oncol (R Coll Radiol).\"  27, \"Prevention and management of radiation-induced late gastrointestinal toxicity.\" 656 (2015)","DOI":"10.1016\/j.clon.2015.06.010"},{"key":"48","doi-asserted-by":"crossref","unstructured":"W Deng, Y Kimura, V Gududuru, et al.  \"Radiat Res.\"  183, \"Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid.\" 465 (2015)","DOI":"10.1667\/RR13830.1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"R Patil, E Szabo, JI Fells, et al.  \"Chem Biol.\"  22, \"Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.\" 206 (2015)","DOI":"10.1016\/j.chembiol.2014.12.009"},{"key":"40","doi-asserted-by":"crossref","unstructured":"D Schaue, ED Micewicz, JA Ratikan, et al.  \"Semin Radiat Oncol.\"  25, \"Radiation and inflammation.\" 4 (2015)","DOI":"10.1016\/j.semradonc.2014.07.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, TM Seed,  \"Cytokine.\"  71, \"Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.\" 22 (2015)","DOI":"10.1016\/j.cyto.2014.08.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"AM Farese  and TJ MacVittie  \"Drugs Today (Barc).\"  51, \"Filgrastim for the treatment of hematopoietic acute radiation syndrome.\" 537 (2015)","DOI":"10.1358\/dot.2015.51.9.2386730"},{"key":"44","doi-asserted-by":"crossref","unstructured":"P Gourmelon, M Benderitter, JM Bertho, et al.  \"Health Phys.\"  98, \"European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal.\" 825 (2010)","DOI":"10.1097\/HP.0b013e3181ce64d4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, DL Bolduc, et al.  \"Radiat Res.\"  188, \"Combined therapy of pegylated G-CSF and Alxn4100TPO improves survival and mitigates acute radiation syndrome after whole-body ionizing irradiation alone and followed by wound trauma.\" 476 (2017)","DOI":"10.1667\/RR14647.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"FA Mettler, AK Gus'kova, I Gusev,  \"Health Phys.\"  93, \"Health effects in those with acute radiation sickness from the Chernobyl accident.\" 462 (2007)","DOI":"10.1097\/01.HP.0000278843.27969.74"}],"container-title":["Radiation Research"],"original-title":[],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T12:23:51Z","timestamp":1577795031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-192\/issue-6\/RR15440.1\/Mitigating-Effects-of-1-Palmitoyl-2-linoleoyl-3-acetyl-rac\/10.1667\/RR15440.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rr15440.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,26]]}}}